» Articles » PMID: 39529914

CerviXpert: A Multi-structural Convolutional Neural Network for Predicting Cervix Type and Cervical Cell Abnormalities

Overview
Journal Digit Health
Date 2024 Nov 12
PMID 39529914
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Cervical cancer, a leading cause of cancer-related deaths among women globally, has a significantly higher survival rate when diagnosed early. Traditional diagnostic methods like Pap smears and cervical biopsies rely heavily on the skills of cytologists, making the process prone to errors. This study aims to develop CerviXpert, a multi-structural convolutional neural network designed to classify cervix types and detect cervical cell abnormalities efficiently.

Methods: We introduced CerviXpert, a computationally efficient convolutional neural network model that classifies cervical cancer using images from the publicly available SiPaKMeD dataset. Our approach emphasizes simplicity, using a limited number of convolutional layers followed by max-pooling and dense layers, trained from scratch. We compared CerviXpert's performance against other state-of-the-art convolutional neural network models, including ResNet50, VGG16, MobileNetV2, and InceptionV3, evaluating them on accuracy, computational efficiency, and robustness using five-fold cross-validation.

Results: CerviXpert achieved an accuracy of 98.04% in classifying cervical cell abnormalities into three classes (normal, abnormal, and benign) and 98.60% for five-class cervix type classification, outperforming MobileNetV2 and InceptionV3 in both accuracy and computational demands. It demonstrated comparable results to ResNet50 and VGG16, with significantly reduced computational complexity and resource usage.

Conclusion: CerviXpert offers a promising solution for efficient cervical cancer screening and diagnosis, striking a balance between accuracy and computational feasibility. Its streamlined architecture makes it suitable for deployment in resource-constrained environments, potentially improving early detection and management of cervical cancer.

References
1.
Boon S, Luk H, Xiao C, Chen Z, Chan P . Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer. Cancers (Basel). 2022; 14(12). PMC: 9220913. DOI: 10.3390/cancers14122913. View

2.
Setayesh T, Kundi M, Nersesyan A, Stopper H, Fenech M, Krupitza G . Use of micronucleus assays for the prediction and detection of cervical cancer: a meta-analysis. Carcinogenesis. 2020; 41(10):1318-1328. DOI: 10.1093/carcin/bgaa087. View

3.
Teixeira J, Vale D, Campos C, Braganca J, Discacciati M, Zeferino L . Organization of cervical cancer screening with DNA-HPV testing impact on early-stage cancer detection: a population-based demonstration study in a Brazilian city. Lancet Reg Health Am. 2023; 5:100084. PMC: 9903591. DOI: 10.1016/j.lana.2021.100084. View

4.
Zhang L, Lu L, Nogues I, Summers R, Liu S, Yao J . DeepPap: Deep Convolutional Networks for Cervical Cell Classification. IEEE J Biomed Health Inform. 2017; 21(6):1633-1643. DOI: 10.1109/JBHI.2017.2705583. View

5.
Fekri-Ershad S, Ramakrishnan S . Cervical cancer diagnosis based on modified uniform local ternary patterns and feed forward multilayer network optimized by genetic algorithm. Comput Biol Med. 2022; 144:105392. DOI: 10.1016/j.compbiomed.2022.105392. View